CL2A-SN-38
Catalog No. A18392
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types.
| Catalog Num | A18392 |
|---|---|
| M. Wt | 1480.61 |
| Formula | C73H97N11O22 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1279680-68-0 |
| Synonyms | |
| SMILES | O=C(O[C@](C1=C(CO2)C(N3CC4=C(CC)C5=CC(O)=CC=C5N=C4C3=C1)=O)(CC)C2=O)OCC6=CC=C(NC([C@H](CCCCN)NC(COCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCN7N=NC(CNC(C8CCC(CN9C(C=CC9=O)=O)CC8)=O)=C7)=O)=O)=O)C=C6 |
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 6.75 mL | 33.77 mL | 67.54 mL |
| 0.5 mM | 1.35 mL | 6.75 mL | 13.51 mL |
| 1 mM | 0.68 mL | 3.38 mL | 6.75 mL |
| 5 mM | 0.14 mL | 0.68 mL | 1.35 mL |
*The above data is based on the productmolecular weight 1480.61. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.